Indeed, Stone et al. demonstrated in an ovarian cancer mouse model that the increase of hepatic thrombopoietin (TPO) production in response to tumor-derived interleukin-6 (Il-6) was responsible for elevated platelet counts [19]. Here, TPO is linked to neoplasm.